Radiomics and radiotherapy
The treatment of cancer with systemic therapy is increasingly personalised to the patient, with drug regimens chosen based on the genetic and molecular profile of the tumour. In comparison, radiotherapy treatment is rarely individualised to the patient, with doses and fractionation schedules based on those used in clinical trials, despite it being known that tumour […]
Angus Killean, Iain Phillips, William Nailon, Duncan McLaren
Edinburgh Cancer Centre, University of Edinburgh